Prince Pharmaceutical Co., Ltd. (TPEX:6935)
27.05
+1.10 (4.24%)
Jul 17, 2025, 1:35 PM CST
Prince Pharmaceutical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 102.8 | 122.57 | 71.96 | 72.5 | 57.08 | Upgrade |
Cash & Short-Term Investments | 102.8 | 122.57 | 71.96 | 72.5 | 57.08 | Upgrade |
Cash Growth | -16.12% | 70.33% | -0.74% | 27.02% | -67.40% | Upgrade |
Accounts Receivable | 116.63 | 108.7 | 72.65 | 62.44 | 57.33 | Upgrade |
Other Receivables | - | - | - | - | 4.9 | Upgrade |
Receivables | 116.63 | 108.7 | 72.65 | 62.44 | 62.23 | Upgrade |
Inventory | 142.37 | 142.12 | 149.86 | 125.44 | 100.73 | Upgrade |
Prepaid Expenses | 2.34 | - | - | - | 2.03 | Upgrade |
Other Current Assets | 0.98 | 18.01 | 7.22 | 14.91 | 0.41 | Upgrade |
Total Current Assets | 365.13 | 391.39 | 301.68 | 275.29 | 222.47 | Upgrade |
Property, Plant & Equipment | 973.6 | 999.83 | 969.34 | 979.79 | 966.52 | Upgrade |
Long-Term Investments | - | - | - | - | 5.73 | Upgrade |
Other Intangible Assets | 0.45 | 1.3 | 1.51 | 2.02 | 2.59 | Upgrade |
Long-Term Deferred Tax Assets | 2.29 | 3.83 | 3.26 | 15.85 | 13.24 | Upgrade |
Other Long-Term Assets | 6.78 | 14.59 | 28.49 | 17.69 | 4.33 | Upgrade |
Total Assets | 1,348 | 1,411 | 1,304 | 1,291 | 1,215 | Upgrade |
Accounts Payable | 108.06 | 84.83 | 55.37 | 68.46 | 39.46 | Upgrade |
Accrued Expenses | 39.98 | - | - | - | 21.46 | Upgrade |
Short-Term Debt | 30 | 30 | 30 | 60 | 105 | Upgrade |
Current Portion of Long-Term Debt | 32.35 | 31.76 | 31.43 | 16.91 | 6.86 | Upgrade |
Current Portion of Leases | 8.07 | 5.01 | 6.97 | 3.19 | 3.69 | Upgrade |
Current Income Taxes Payable | - | 4.35 | - | - | - | Upgrade |
Current Unearned Revenue | 5.45 | 2.62 | 14.78 | 10.91 | 8.39 | Upgrade |
Other Current Liabilities | 10.81 | 53.38 | 51.61 | 41.67 | 9.8 | Upgrade |
Total Current Liabilities | 234.71 | 211.94 | 190.16 | 201.14 | 194.66 | Upgrade |
Long-Term Debt | 267.27 | 299.49 | 330.92 | 362.06 | 309.91 | Upgrade |
Long-Term Leases | 123.11 | 124.1 | 123.78 | 123.83 | 99.52 | Upgrade |
Long-Term Deferred Tax Liabilities | 1.1 | 0.93 | 1.05 | 0.74 | 0.02 | Upgrade |
Total Liabilities | 626.19 | 636.47 | 645.91 | 687.77 | 604.1 | Upgrade |
Common Stock | 366.05 | 361.93 | 331.93 | 331.93 | 331.93 | Upgrade |
Additional Paid-In Capital | 363.93 | 348.49 | 282.22 | 279.29 | 279.29 | Upgrade |
Retained Earnings | -7.92 | 53.81 | 44.23 | -8.36 | -0.45 | Upgrade |
Comprehensive Income & Other | - | 10.24 | - | - | - | Upgrade |
Shareholders' Equity | 722.06 | 774.47 | 658.38 | 602.87 | 610.77 | Upgrade |
Total Liabilities & Equity | 1,348 | 1,411 | 1,304 | 1,291 | 1,215 | Upgrade |
Total Debt | 460.8 | 490.36 | 523.11 | 565.99 | 524.97 | Upgrade |
Net Cash (Debt) | -357.99 | -367.79 | -451.15 | -493.49 | -467.89 | Upgrade |
Net Cash Per Share | -9.79 | -10.06 | -13.54 | -14.87 | -14.30 | Upgrade |
Filing Date Shares Outstanding | 36.61 | 36.19 | 33.19 | 33.19 | 33.19 | Upgrade |
Total Common Shares Outstanding | 36.61 | 36.19 | 33.19 | 33.19 | 33.19 | Upgrade |
Working Capital | 130.42 | 179.45 | 111.52 | 74.15 | 27.81 | Upgrade |
Book Value Per Share | 19.73 | 21.40 | 19.83 | 18.16 | 18.40 | Upgrade |
Tangible Book Value | 721.61 | 773.16 | 656.86 | 600.85 | 608.18 | Upgrade |
Tangible Book Value Per Share | 19.71 | 21.36 | 19.79 | 18.10 | 18.32 | Upgrade |
Land | 102.92 | 102.92 | 102.92 | 102.92 | 102.92 | Upgrade |
Buildings | 580.78 | 580.78 | 578.84 | 578.62 | 578.27 | Upgrade |
Machinery | 462.94 | 441.82 | 365.91 | 336.1 | 313.48 | Upgrade |
Updated Aug 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.